Zobrazeno 1 - 10
of 224
pro vyhledávání: '"H. von Euler"'
Publikováno v:
The Veterinary Journal. 197:854-860
Determination of serum thymidine kinase 1 (STK1) activity has been used as a proliferation marker for neoplastic diseases in both human and veterinary medicine. The purpose of this study was to determine STK1 activity and enzyme levels in different d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecc0d801849bf279662b2b6e629856a2
https://doi.org/10.1016/j.tvjl.2013.05.036
https://doi.org/10.1016/j.tvjl.2013.05.036
Publikováno v:
Veterinary and Comparative Oncology. 11:243-255
A new formulation of water-soluble paclitaxel (Paccal® Vet) has been developed for canine cancer patients, without the need for pre-medication (traditionally required in non-water-soluble paclitaxel formulations). The objective of the study was to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ff06767429adb1bccbd784fbb4224db
https://doi.org/10.1111/j.1476-5829.2011.00314.x
https://doi.org/10.1111/j.1476-5829.2011.00314.x
Autor:
Patricio Rivera, H. von Euler
Publikováno v:
Veterinary Pathology; Vol 48
The high incidence of mammary tumor disease reported in certain canine breeds suggests a significant genetic component, as has already been described in human familial breast cancer—in BRCA1- and BRCA2-associated breast cancer in particular. The id
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f7ac2e85622979259e6f70721ced792
Autor:
Salomé S. Pinho, Achim D. Gruber, Giuseppe Sarli, Fátima Gärtner, Robert Klopfleisch, H. von Euler
Publikováno v:
Veterinary Pathology; Vol 48
Studies focusing on the molecular basis of canine mammary tumors (CMT) have long been hampered by limited numbers of molecular tools specific to the canine species. The lack of molecular information for CMT has impeded the identification of clinicall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::649e3ceb5d07a6355bb9810e36020aa6
Autor:
Staffan Eriksson, H. von Euler
Publikováno v:
Veterinary and Comparative Oncology. 9:1-15
As cell proliferation is one of the hallmarks of cancer, various types of proliferation markers are used as important tools in diagnosis, prognosis, treatment decision-making and follow-up in clinical oncology. The S phase-specific protein thymidine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89972099ef77700ee69a8ecb6f3f1516
https://doi.org/10.1111/j.1476-5829.2010.00238.x
https://doi.org/10.1111/j.1476-5829.2010.00238.x
Publikováno v:
Veterinary Record; Vol 163
Karolinska Institutet
Karolinska Institutet
Fifty-one dogs (27 diabetic dogs, four that had recovered from diabetes and 20 healthy control dogs) were given 0.5 or 1.0 mg glucagon intravenously. Blood samples were taken before the injection and 10 and 20 minutes after it. Samples were analysed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f61fabf5be3bf6fed6b80001e656028
https://doi.org/10.1136/vr.163.9.266
https://doi.org/10.1136/vr.163.9.266
Publikováno v:
Bioelectrochemistry (Amsterdam, Netherlands)
Background : Several authors have recently reported encouraging results from Electrochemical treatment (EChT) in malignant tumours. However, EChT is not established and mechanisms are not completely understood. In vivo studies were conducted to evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::749bb5fc497a33dfcde716de64f4da27
https://doi.org/10.1016/j.bioelechem.2003.10.008
https://doi.org/10.1016/j.bioelechem.2003.10.008
Publikováno v:
Veterinary journal (London, England : 1997). 205(2)
Serum thymidine kinase (sTK) activity is a tumour marker used as a prognostic indicator for lymphoma in humans, dogs and cats. The aim of this study was to evaluate the clinical utility of sTK as a biomarker for lymphoma in horses. Serum samples were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c885bf8f299b0e0d3038e1e937806d3
https://pubmed.ncbi.nlm.nih.gov/25744802
https://pubmed.ncbi.nlm.nih.gov/25744802
Publikováno v:
Peptides. 22:613-621
The metabolism of three mu-selective opioid tetrapeptide agonists, Tyr-D-Arg-Phe-Nva-NH(2) (TArPN), Tyr-D-Arg-Phe-Phe-NH(2) (TArPP), and Tyr-D-Ala-Phe-Phe-NH(2) (TAPP), was investigated in different rat tissues. High metabolic activity (20% peptide r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d288336230ee6e31187cce5169c08e6e
https://doi.org/10.1016/s0196-9781(01)00328-x
https://doi.org/10.1016/s0196-9781(01)00328-x
Autor:
Cheryl A. London, Mona P. Rosenberg, Alexandra Sahora, Anthony Rusk, Nicole C. Northrup, L. Fulton, Mary K. Klein, Sara Westberg, Brenda Phillips, David M. Vail, S. Siegel, Elizabeth A. McNiel, J.L. Winter, Lisa G. Barber, Joanna S. Morris, H. von Euler, Robyn E. Elmslie, M. Martano, G. S. Post, Chand Khanna, Johannes Hirschberger, Craig A. Clifford, David M. Ruslander, Gerry Polton, Douglas H. Thamm
Background Effective treatments for dogs with advanced stage mast cell tumors (MCT) remain a pressing need. A micellar formulation of paclitaxel (paclitaxel [micellar]) has shown promise in early-phase studies. Hypothesis/Objectives The objective was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e772b44abe3b4223117ff140fd9d22e0
http://hdl.handle.net/2318/90904
http://hdl.handle.net/2318/90904
